• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿肠衰竭的病因和治疗:重点是非消化系统病因。

Etiology and Management of Pediatric Intestinal Failure: Focus on the Non-Digestive Causes.

机构信息

Hepatology Gastroenterology and Nutrition Unit, "Bambino Gesù" Children Hospital, 00165 Rome, Italy.

Pediatric Unit, Department of Medical and Surgical Sciences for Mothers, Children and Adults, University of Modena and Reggio Emilia, 41121 Modena, Italy.

出版信息

Nutrients. 2021 Feb 27;13(3):786. doi: 10.3390/nu13030786.

DOI:10.3390/nu13030786
PMID:33673586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7997222/
Abstract

BACKGROUND

Intestinal failure (IF) is defined as reduction in functioning gut mass below the minimal amount necessary for adequate digestion and absorption. In most cases, IF results from intrinsic diseases of the gastrointestinal tract (digestive IF) (DIF); few cases arise from digestive vascular components, gut annexed (liver and pancreas) and extra-digestive organs or from systemic diseases (non-digestive IF) (NDIF). The present review revised etiology and treatments of DIF and NDIF, with special focus on the pathophysiological mechanisms, whereby NDIF develops.

METHODS

We performed a comprehensive search of published literature from January 2010 to the present by selecting the following search strings: "intestinal failure" OR "home parenteral nutrition" OR "short bowel syndrome" OR "chronic pseudo-obstruction" OR "chronic intestinal pseudo-obstruction" OR "autoimmune enteropathy" OR "long-term parenteral nutrition".

RESULTS

We collected overall 1656 patients with well-documented etiology of IF: 1419 with DIF (86%) and 237 with NDIF (14%), 55% males and 45% females. Among DIF cases, 66% had SBS and among NDIF cases 90% had malabsorption/maldigestion.

CONCLUSIONS

The improved availability of diagnostic and therapeutic tools has increased prevalence and life expectancy of rare and severe diseases responsible for IF. The present review greatly expands the spectrum of knowledge on the pathophysiological mechanisms through which the diseases not strictly affecting the intestine can cause IF. In view of the rarity of the majority of pediatric IF diseases, the development of IF Registries is strongly required; in fact, through information flow within the network, the Registries could improve IF knowledge and management.

摘要

背景

肠衰竭(IF)被定义为消化和吸收所需的最低肠道功能减少。在大多数情况下,IF 是由胃肠道(消化 IF)(DIF)的内在疾病引起的;少数情况是由消化血管成分、附属肠道(肝和胰腺)和非消化器官或系统性疾病(非消化 IF)(NDIF)引起的。本综述修订了 DIF 和 NDIF 的病因和治疗方法,特别关注 NDIF 发展的病理生理机制。

方法

我们通过选择以下搜索字符串,对 2010 年 1 月至目前发表的文献进行了全面搜索:“肠衰竭”或“家庭肠外营养”或“短肠综合征”或“慢性假性肠梗阻”或“慢性肠假性肠梗阻”或“自身免疫性肠病”或“长期肠外营养”。

结果

我们共收集了 1656 例病因明确的 IF 患者:1419 例为 DIF(86%),237 例为 NDIF(14%),男性占 55%,女性占 45%。在 DIF 病例中,66%为 SBS,而在 NDIF 病例中,90%为吸收不良/消化不良。

结论

诊断和治疗工具的改进提高了罕见和严重疾病导致 IF 的患病率和预期寿命。本综述极大地扩展了知识范围,了解了并非严格影响肠道的疾病如何导致 IF 的病理生理机制。鉴于大多数儿科 IF 疾病的罕见性,强烈需要开发 IF 登记处;事实上,通过网络内的信息流,登记处可以提高 IF 的知识和管理水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ec/7997222/043d9c595848/nutrients-13-00786-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ec/7997222/043d9c595848/nutrients-13-00786-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ec/7997222/043d9c595848/nutrients-13-00786-g001.jpg

相似文献

1
Etiology and Management of Pediatric Intestinal Failure: Focus on the Non-Digestive Causes.小儿肠衰竭的病因和治疗:重点是非消化系统病因。
Nutrients. 2021 Feb 27;13(3):786. doi: 10.3390/nu13030786.
2
[Intestinal failure].[肠衰竭]
Rev Prat. 2001 May 15;51(9):977-82.
3
Irreversible intestinal failure.不可逆性肠衰竭
J Pediatr Gastroenterol Nutr. 2004 Mar;38(3):250-69. doi: 10.1097/00005176-200403000-00006.
4
Nutritional deficiencies in intestinal failure.肠衰竭中的营养缺乏
Pediatr Clin North Am. 2009 Oct;56(5):1185-200. doi: 10.1016/j.pcl.2009.07.005.
5
ESPEN guidelines on chronic intestinal failure in adults.ESPEN 成人慢性肠衰竭临床指南。
Clin Nutr. 2016 Apr;35(2):247-307. doi: 10.1016/j.clnu.2016.01.020. Epub 2016 Feb 8.
6
Gastroesophageal Reflux Disease and Foregut Dysmotility in Children with Intestinal Failure.儿童肠衰竭相关的胃食管反流病和前肠动力障碍
Nutrients. 2020 Nov 18;12(11):3536. doi: 10.3390/nu12113536.
7
Causes and management of intestinal failure in children.儿童肠衰竭的病因与管理
Gastroenterology. 2006 Feb;130(2 Suppl 1):S16-28. doi: 10.1053/j.gastro.2005.12.002.
8
Survival rate and prognostic factors in patients with intestinal failure.肠衰竭患者的生存率及预后因素
Dig Liver Dis. 2004 Jan;36(1):46-55. doi: 10.1016/j.dld.2003.09.015.
9
Intestinal Failure: A Description of the Problem and Recent Therapeutic Advances.肠衰竭:问题描述和近期治疗进展。
Clin Perinatol. 2020 Jun;47(2):323-340. doi: 10.1016/j.clp.2020.02.008. Epub 2020 Mar 4.
10
Clinical assessment of the child with intestinal failure.肠衰竭患儿的临床评估
Semin Pediatr Surg. 2010 Feb;19(1):10-9. doi: 10.1053/j.sempedsurg.2009.11.002.

引用本文的文献

1
Paediatric Congenital Enteropathies: Clinical and Histological Review.小儿先天性肠道病:临床与组织学综述
Diagnostics (Basel). 2025 Apr 8;15(8):946. doi: 10.3390/diagnostics15080946.
2
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.基于肽的药物研发进展:递送平台、治疗药物与疫苗
Signal Transduct Target Ther. 2025 Mar 5;10(1):74. doi: 10.1038/s41392-024-02107-5.
3
Macronutrients Management for Growth in Neonates with Congenital Gastrointestinal Malformation.先天性胃肠道畸形新生儿生长的宏量营养素管理。

本文引用的文献

1
Use of GLP-2 May Herald a New Era of Improved Outcome of Short Bowel Syndrome-associated Intestinal Failure.胰高血糖素样肽-2的应用可能预示着短肠综合征相关肠衰竭治疗效果改善的新时代。
J Pediatr Gastroenterol Nutr. 2020 Dec;71(6):697-698. doi: 10.1097/MPG.0000000000002924.
2
Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data.儿科短肠综合征中特杜古肽的应用经验:首个真实世界数据。
J Pediatr Gastroenterol Nutr. 2020 Dec;71(6):734-739. doi: 10.1097/MPG.0000000000002899.
3
To Wean or Not to Wean: The Role of Autologous Reconstructive Surgery in the Natural History of Pediatric Short Bowel Syndrome on Behalf of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP).
Med Sci Monit. 2022 Nov 22;28:e938106. doi: 10.12659/MSM.938106.
4
Cow's milk allergy non-responsive to amino acid-based formula? A successful transplanted patient with immune dysregulation, polyendocrinopathy, enteropathy, and X-linked syndrome.对氨基酸配方奶粉无反应的牛奶过敏?一例患有免疫失调、多内分泌腺病、肠病和X连锁综合征的成功移植患者。
Clin Case Rep. 2021 Oct 5;9(10):e04900. doi: 10.1002/ccr3.4900. eCollection 2021 Oct.
5
Malnutrition in Pediatric Chronic Cholestatic Disease: An Up-to-Date Overview.儿科慢性胆汁淤积性疾病中的营养不良:最新综述。
Nutrients. 2021 Aug 13;13(8):2785. doi: 10.3390/nu13082785.
是否断奶:小儿短肠综合征自然史中自体重建手术的作用 代表意大利胃肠病学、肝病学和营养学学会 (SIGENP)
Nutrients. 2020 Jul 18;12(7):2136. doi: 10.3390/nu12072136.
4
Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation.甘露糖磷酸异构酶-先天性糖基化障碍的诊断和管理共识指南
J Inherit Metab Dis. 2020 Jul;43(4):671-693. doi: 10.1002/jimd.12241. Epub 2020 Apr 21.
5
Protein-Losing Enteropathy Following Fontan Palliation.Fontan 姑息术后蛋白丢失性肠病。
Can J Cardiol. 2019 Dec;35(12):1857-1860. doi: 10.1016/j.cjca.2019.07.625. Epub 2019 Jul 26.
6
Parenteral nutrition use in children with cancer.儿童癌症患者的肠外营养使用。
Pediatr Blood Cancer. 2019 Dec;66(12):e28000. doi: 10.1002/pbc.28000. Epub 2019 Sep 18.
7
Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study.短肠综合征相关肠衰竭儿科患者应用特杜古肽的安全性和疗效:一项 24 周、III 期研究。
JPEN J Parenter Enteral Nutr. 2020 May;44(4):621-631. doi: 10.1002/jpen.1690. Epub 2019 Sep 8.
8
Eosinophilic gastroenteritis: diagnosis and clinical perspectives.嗜酸性胃肠炎:诊断与临床展望
Clin Exp Gastroenterol. 2019 Jun 5;12:239-253. doi: 10.2147/CEG.S173130. eCollection 2019.
9
Home parenteral nutrition in pediatric patients with intestinal insufficiency.肠道功能不全小儿患者的家庭肠内营养
Rev Chil Pediatr. 2019;90(1):60-68. doi: 10.32641/rchped.v90i1.800. Epub 2019 Jan 21.
10
Pediatric Intestinal Pseudo-obstruction: Impact of Neonatal and Later Onset on Clinical and Nutritional Outcomes.小儿肠道假性梗阻:新生儿期及迟发型对临床和营养结局的影响
J Pediatr Gastroenterol Nutr. 2019 Aug;69(2):212-217. doi: 10.1097/MPG.0000000000002373.